GlassScriptPhysician profile
James Kenneth Hoffman
NPI 1487659405
$650.94
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $83.77 · 2021: $27.66.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $210.45 | 2019 | |
| Glaxosmithkline, LLC. | $124.40 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $48.79 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $41.38 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $31.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.98 | 2019-2020 | |
| Allergan, INC. | $22.19 | 2020 | |
| Daiichi Sankyo INC. | $21.71 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.89 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.63 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.44 | 2019 | |
| Merck Sharp & Dohme LLC | $19.40 | 2019 | |
| Abbvie INC. | $14.17 | 2021 | |
| Boston Scientific Corporation | $13.49 | 2021 | |
| Lilly USA, LLC | $13.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.